Introduction
Leprosy and tuberculosis are the main mycobacterial infections affecting human being. In spite of the effective chemotherapy available, these diseases are among the major health problems in the developing world. The situation has been complicated because of nonavai lability of efficient and specific diagnostic tests and effective vaccines. Lepromin and tuber culin skin tests have long been used but are only of prognostic value as these reagents are not specific for M. leprae and M. tuberculosis. Similarily, BCG vaccines against both diseases J have been tried, but with variable effects (1) (2) (3) (4) (5) . Whole bacilli are antigenically quite complex and may have suppressor antigens/epitopes activating suppressor T cells (6, 7) which could suppress the function of helper/effector T cells (7, 8) . It is, therefore, important to identify antigens/epitopes of M. leprae and M. tuberculosis recognized by helper T cells as a first step towards the development of new vaccines and specific diagnostic reagents. The recent developments in cloning of mycobacterial genomic DNA in foreign hosts and the isolation of recombinants expressing major mycobacterial protein antigens defined by monoclonal anti bodies (9, 10) have made the above objective fe asible. Here, we report the identification of recombinant M. leprae and M. tuberculosis antigens recognized by human CD4+ T-cell clo nes.
Materials and methods

MYCOBACTERIAL ANTIGEN INDUCED HUMAN T-CELL CLONES
One hundred and twenty one BCG induced T-cell clones from 9 BCG vaccinated healthy subjects (11), 42 M. leprae induced T-cell clones from 6 volunteers vaccinated with killed M. leprae (12) and 52 M. tuberculosis induced T-cell clones from 4 tuberculosis patients (13) were raised from peripheral blood mononuclear cells (PBMC). These clones were grown and maintained in vitro by weekly fe eding of specific antigen and autologous fe eder cells + 100 U recombinant interleukin-2 (IL-2) added twice a week. antigens recognized by mon oclonal antibodies were prepared by inducing ,,-gtll recombinant lysogens of the strain Y1089 according to the method described earlier (12) . Viscosity of the crude lysates was re duced by brief sonication (3 x 10 s) and protein content was determined by measurement of 00 280. Lysates were sterilized by niillipore filtration and stored frozen at -70°C in aliguots.
MYCOBACTERIAL ANTIGENS
ANTIGEN INDUCED PROLIFERATION OF T-CELL CLONES 1 x 104 cloned T cells were added to the wells of 96 well flat bottom plates with adherent cells from 1 x 105 irradiated autologous PBMC. Antigens were added in triplicate . The plates were incubated at 37°C in a humidified atmosphere of 5 % C02 and 95 % air. 0.045 MBg 3 H-thymidine was added to the cultures during the last 4 h of a 72 h incubation period. Cul tures were harvested and radioactivity incorporated was determined by standard methods (14) . Median CPM values from triplicates have been used to express the results. A clone was considered responder to a given antigen when 6, CPM was ;:: 1000 and T / C > 2, where INTERLEUKIN-2 AND GAMMA INTERFERON PRODUCTION AND ASSAY I x 105 cloned T cells were added into the wells of 24 well costar plates with adherent cells from I x 106 irradiated PBMC and either M. leprae (5 x 107 bacilli/ml) or BCG (20 f,lg/ml, wet weight) in 1 ml RPMI-1 640 + 15 % AB serum + I % Penicillin-Streptomycin. The plates were incubated in a humidified atmosphere of 5 % C02 and 95 % air at 37°C. Cell free supernatants were collected after 18 h for IL-2 assay and after 48 h for interferon assay by methods described earlier (11). The bulk of interferon activity in the supernatants from T-cell clones + antigen + adherent cells, was eliminated by treatment at pH-2 and anti gamma inter feron antibodies, indicating that it was due to gamma interferon (INF-y) .
CYTOTOXICITY ASS A Y Adherent cells were obtained from I x 106 PBMC in 24 well costar plates. BCG at 20 f,lg/ml and M. leprae at 5 x 107 bacilli/ml were added into each well together with 2 x 105 cloned cells. Control wells did not have T-cell clones. The plates were incubated at 37°C for 6 days. Nonadherent cells were removed and adherent cells were further incubated at 37°C for 30 min in 0.01 % solution of neutral red in saline + 10 % FBS. The wells were washed 3 times with saline and neutral red taken up by viable macrophages was released and percentage cy totoxicity was calculated according to the method of Parish and Mullbacher (15) .
Results
GENERAL CHARACTERISTICS OF T-CELL CLONES
All the T-cell clones raised and maintained from the three groups of people were CD4+ and CD8-, except one clone from a BCG vaccinated subject which was CD8+ CD4-. Testing with a battery of mycobacterial antigens revealed that clones from all three groups recog nized epitopes of varying specificity ( Table I ). Among 118 clones tested, 31 were specific to the antigens against which they were raised, and others were limited to broadly crossreactive in proliferative assays ( Table I) .
Antigen specificity of 3 M. leprae raised T-cell clones tested was also maintained in other test systems. For example, only M. leprae antigens but not PPD could induce IL-2 and IFN-y production from these clones ( Table 2) . Similarly the clones exhibited cytotoxic ac tivity against antigen presenting cells in the presence of M. leprae, whereas cytotoxicity was not observed in the presence of BCG ( Table 2) .
Responses of the T-cell clones from all 3 groups of subjects to BCG and M. tuberculosis parallelled closely. Although, the majority of M. leprae raised T-cell clones from all indi viduals responded to BCG (68 %) and to M. tuberculosis (63 %), only few clones (9 %) from 3 of 7 BCG vaccinated subjects and 23 % clones from 2 of the 3 tuberculosis patients responded to M. leprae (Table 3) .
IDENTIFICATION OF RECOMBINANT MYCOBACTERIAL ANTIGENS BY T-CELL CLONES
A total of ninety eight T-cell clones (24 T-cell clones from BCG vaccinated subjects, 22 T-cell clones from killed M. leprae vaccinated volunteers and 52 T-cell clones from tuber culosis patients) were tested for their reactivity to the major protein antigens of M. leprae and M. tuberculosis expressed from recombinant DNA and identified by monoclonal antibodies. Five specific T cell clones from 2 M. leprae vaccinated subjects responded to the E. coli lysate containing the 18K protein of M. leprae (12) . One crossreactive T-cell clone from an other M. leprae vaccinated subject responded to the M. leprae as well as to the M. tuber culosis 65K proteins (Table 4) . From tuberculosis patients, one specific T-cell clone proli- 
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The clones with initials BK, TK and LK were raised from BCG vaccinated subjects, tuberculosis patient and M. leprae vaccinated subjects, respectively. The values showing significant proliferation (LCPM � 1000 and TIC c 2) are in italics. The majority of T-cell clones from killed M. leprae vaccinated subjects and from tuber culosis patients and all of the 24 clones from BCG vaccinated subjects did not respond to the M. leprae or M. tuberculosis recombinant proteins identified by monoclonal antibodies (Table 5) . Table 5 . Numbers of T-cell clones fr om diff erent groups of subjects responding to recom binant mycobacterial antigens. In this and earlier reports we have described the characteristics of human T-cell clones from BCG vaccinated subjects (11), M. leprae vaccinated volunteers (12) and tuberculosis pa tients (13) . The T-cell clones from all three groups had identical requirements of antigen and antigen presenting cells for their continuous growth in vitro. They were CD4+ CD8-and re cognized epitopes of varied specificity ranging from highly specific to broadly crossreactive. Almost all of the BCG raised T cell clones responded to M. tuberculosis H37Rv and vice versa. The majority of T-cell clones raised against M. leprae also responded to BCG and M. tuberculosis H37Rv, but only few clones raised against BCG and Predominance of mycobacterial antigen reactive CD4+ T cell clones from the PBMC of either normal subjects or diseased people have been reported by other investigators as well (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . This could be due to the intrinsic property of mycobacterial antigens. Severity of the disease might also be a reason. The T-cell clones from tuberculoid leprosy patients were ex clusively CD4+ (19, 20) , whereas T-cell clones from a borderline lepromatous leprosy pa tient were both CD4+ and CD8+ (7), and the 2 suppressor clones raised from lepromatous leprosy skin lesions were CD8+ (8) . Alternatively, CD8+ cells might have special require ments for the long term propagation in vitro (21) .
The mycobacterial antigen induced T-cell clones were also producing multiple biologi cally important Iymphokines like IL-2, IFN-y and granulocyte-macrophage colony stimulat ing factor (11 and table 3). These Iymphokines may have a direct or indirect role in protec tion against infections by recruiting and activating macrophages, which are the hosts for in tracellular parasites like mycobacteria. However, the same T-cell clones were also cytotoxic for such macrophages in the presence of specific mycobacteria (22 and Table 4 ). It is possi ble that such cytotoxic mechanisms may help the destruction of invading organisms by kill ing those macrophages which have become incompetent to kill the mycobacteria. Such mac rophages will otherwise become a fertile soil for bacterial growth and thus may provide an escape mechanism for the infection. However, the immune system may possibly fo il such at tempts by killing these macrophages via specific cytotoxic cells.
Our studies and a report from others (23) have demonstrated the potential use of T-cell clones in identifying recombinant mycobacterial antigens from crude E. coli Iysates which is not possible using peripheral blood lymphocytes due to toxicity of the crude Iysates. This toxic effect is less severe on the reactivity of T -cell clones because of shorter incubation per-129 iod to assess their reactivity as compared to peripheral blood lymphocytes. Using this system we have identified T-cell clones exclusively reacting either with an 18K protein of M. leprae or with a 19K protein of M. tuberculosis. These two proteins of comparable molecular weight are specific to the respective mycobacteria as their DNA do not hybridize (RA Young, personal communication). One specific clone from a tuberculosis patient responded to the 65K protein of M. tuberculosis but not to the 65K protein of M. leprae. DNA encoding these two proteins have been shown to hybridize and their amino acid sequences are quite si milar except for a small region (RA Young, personal communication). However, the epi tope seen by the T-cell clone in our system seems to be specific for the M. tuberculosis complex, as this clone did not respond to other mycobacteria tested. Crossreactive epitopes are also present on the 65K protein of M. tuberculosis as suggested from our work (Table 4) and the work from other laboratories (23) . Studies are in progress to determine the nature of the epitopes seen by the T-cell clones so that corresponding peptides can be synthesized and their clinical relevance, if any, evaluated.
The mouse monoclonal antibodies raised against M. leprae and M. tuberculosis in differ ent laboratories react to a limited number of proteins when tested either against the Iysates of these mycobacteria (24) or the recombinant proteins made in foreign hosts (10, 24) . Howev er, the majority of human T-cell clones did not respond to these recombinant proteins. This could either be due to the reason that epitopes seen by T cells reside on proteins not recogn ized by antibodies, or that the repertoire of mouse B cells with respect to response to the my cobacterial proteins is quite limited. Alternatively, our T-cell clones may recognize epitopes/ antigens nonprotein in nature .
